Participants received either oral fenebrutinib twice daily or oral teriflunomide once daily for at least 96 weeks.

The trial is set to begin dosing patients this quarter, in line with prior guidance from Serina Therapeutics.

Touted by some as a miracle cure-all, stacking is attracting attention for another reason, too: a lack of long-term data and ...

TD Cowen 46th Annual Health Care Conference March 3, 2026 11:10 AM ESTCompany ParticipantsRoopal Thakkar - Executive VP of Research ...

Salmon is the UK's most popular fish - in 2024, supermarkets sold more than 73,000 tonnes of it - and last year, it accounted for a third of all fish sales.

A new survey suggests that most Americans are familiar with statins, but most are not aware of nonstatin cholesterol-lowering therapies and other tools to combat heart disease.The survey of 1,006 ...

Hello, ladies and gentlemen. Thank you for standing by, and welcome to Zai Lab's Fourth Quarter and Full Year 2025 Financial Results Conference Call. [Operator Instructions] As a reminder, today's ...

A look at the biologics, gene therapies, and vaccines most likely to reshape care —and manufacturing—in the year ahead.

Xeris Biopharma(NASDAQ:XERS) announced major revenue acceleration and recorded net income for the first time, driven by robust demand for Recorlev, Gvoke, and Keveyis. Recorlev's customer base nearly ...

AbCellera Biologics Inc. (NASDAQ: ABCL) Q4 2025 Earnings Call Transcript February 24, 2026 AbCellera Biologics Inc. beats ...

Two patients died after having liposuction-like procedures at two separate San Diego cosmetic surgery offices, court records show.

Touted by some as a ‘miracle cure-all’, stacking is attracting attention for another reason too: a lack of long-term data and clear regulation. “Peptide stacking simply means using two or more ...